Lobbying

American Vapor Manufacturers's latest lobbying report covers Q3 2023, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Health Issues and Manufacturing.

American Vapor Manufacturers

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

American Vapor Manufacturers lobbying by quarter
American Vapor Manufacturers lobbying by quarter
QuarterAmountReports
Q4 2022$72K2
Q1 2023$60K2
Q2 2023$02
Q3 2023$01
Q4 2023$00
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Budget and appropriations$120K · 2 reports
  • Health issues$6,000 · 4 reports
  • Manufacturing$6,000 · 4 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES6 reports
  • SENATE6 reports
  • Food & Drug Administration (FDA)5 reports
  • Health & Human Services, Dept of (HHS)5 reports

Firms it paid

Firm
Ervin Graves Strategy Group$120K3 quarters
Trimpa Group$12K4 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
23/11/14for Q2 2023Ervin Graves Strategy GroupUnder $5,000
23/11/03for Q4 2022Ervin Graves Strategy Group$60K
23/09/12for Q3 2023Trimpa GroupUnder $5,000
23/09/12for Q2 2023Trimpa GroupUnder $5,000
23/09/12for Q1 2023Trimpa GroupUnder $5,000
23/07/20for Q2 2023Trimpa Group$12K
23/07/19for Q2 2023Ervin Graves Strategy GroupUnder $5,000
23/04/19for Q1 2023Ervin Graves Strategy Group$60K
23/03/15for Q1 2023Trimpa Group$12K
23/01/18for Q4 2022Ervin Graves Strategy Group$60K
23/01/13for Q4 2022Trimpa Group$12K